About: Dendritic cell-based anticancer vaccination in immunotherapy of metastatic renal carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dendritic cell-based anticancer vaccination in immunotherapy of metastatic renal carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
rdfs:seeAlso	http://www.mzm.cz/fileadmin/user_upload/publikace/casopisy/fm_49_2_2013/fm-2-2013-abstract-06.pdf
Description	Dendritic cell-based anticancer vaccination is a newly studied and developed approach in cancer immunotherapy based on the stimulation of immune system and supporting natural resistance to cancer via tumor-specific antigens. Cancer immunotherapy is less damaging to the rest of the body in contrast to chemo- or radio-therapy, therefore cancer therapeutic vaccines are not associated with any serious side effects. Dendritic-cell based anticancer vaccinations are used these days as a supporting treatment (in clinical trials) after surgical tumor removal. Their crucial effects seem to be in the prevention of relapse and extended remission period or patients’ survival via generation of specific immune response able to clear and/or suppress any residual cancer cells. Dendritic cell-based anticancer vaccination is a newly studied and developed approach in cancer immunotherapy based on the stimulation of immune system and supporting natural resistance to cancer via tumor-specific antigens. Cancer immunotherapy is less damaging to the rest of the body in contrast to chemo- or radio-therapy, therefore cancer therapeutic vaccines are not associated with any serious side effects. Dendritic-cell based anticancer vaccinations are used these days as a supporting treatment (in clinical trials) after surgical tumor removal. Their crucial effects seem to be in the prevention of relapse and extended remission period or patients’ survival via generation of specific immune response able to clear and/or suppress any residual cancer cells. (en)
Title	Dendritic cell-based anticancer vaccination in immunotherapy of metastatic renal carcinoma Dendritic cell-based anticancer vaccination in immunotherapy of metastatic renal carcinoma (en)
skos:prefLabel	Dendritic cell-based anticancer vaccination in immunotherapy of metastatic renal carcinoma Dendritic cell-based anticancer vaccination in immunotherapy of metastatic renal carcinoma (en)
skos:notation	RIV/00209805:_____/13:#0000443!RIV14-MZ0-00209805
http://linked.open...avai/riv/aktivita	I P
http://linked.open...avai/riv/aktivity	I, P(ED2.1.00/03.0101), P(NT11137)
http://linked.open...iv/cisloPeriodika	2
http://linked.open...vai/riv/dodaniDat	2014
http://linked.open...aciTvurceVysledku	Vojtěšek, Bořivoj Valík, Dalibor Matoulková, Eva
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Masarykův onkologický ústav
http://linked.open...dnocenehoVysledku	68360
http://linked.open...ai/riv/idVysledku	RIV/00209805:_____/13:#0000443
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	renal carcinoma; dendritic cells; cancer immunotherapy (en)
http://linked.open.../riv/klicoveSlovo	renal carcinoma dendritic cells cancer immunotherapy
http://linked.open...odStatuVydavatele	CZ - Česká republika
http://linked.open...ontrolniKodProRIV	[F6EBFEBE8172]
http://linked.open...i/riv/nazevZdroje	Folia Mendeliana
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	3 (xsd:int)
http://linked.open...cetTvurcuVysledku	4 (xsd:int)
http://linked.open...vavai/riv/projekt	Regional Centre for Applied Molecular Oncology (RECAMO) Anti-tumour therapy - vaccination with dendritic cells in patients with metastatic renal cell carcinoma. Phase II clinical study.
http://linked.open...UplatneniVysledku	2013
http://linked.open...v/svazekPeriodika	49
http://linked.open...iv/tvurceVysledku	Valík, Dalibor Vojtěšek, Bořivoj Matoulková, Eva
issn	0085-0748
number of pages	4 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 91 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software